Breast cancer (BC) is a major public health problem internationally. Although illness survival rates have improved, patients usually suffer multiple symptoms, both physical and psychological, which can affect their quality of life (QoL). The main aim of this study was to evaluate depressive symptoms, anxiety and the QoL of people with BC. An observational, cross-sectional study was carried out at Badajoz University Hospital (Spain). A total of 200 women with BC were included. EORTC QLQ-C30 and QLQ-BR23 questionnaires were used to assess QoL. Patients were screened for depressive symptoms using the Beck Depression Inventory (BDI) and for state anxiety and trait anxiety using the State Anxiety Inventory (STAI). Thirty-eight percent of the patients in the sample had moderate to severe anxiety, which was related to the time of diagnosis, advanced stage of illness and surgical treatment. We found that 28% of patients had depressive symptoms, related mainly with time of diagnosis, adjuvant therapy and number of cycles of chemotherapy (CT). Patients with the longest time since diagnosis, in stage III, and in treatment with CT, especially those with the greatest number of cycles, had the worst scores in QoL. We found a positive association between depressive symptoms and anxiety with QoL in patients with BC.
Background: Chemotherapy-related cognitive impairment (CRCI), or “chemobrain,” isdefined as a phenomenon of cognitive deficits in cancer patients after chemotherapy and is characterized by deficits in areas of cognition, including memory, attention, speed of processing, and executive function, which seriously affect quality of life. The purpose of this study is to investigate the impact of CRCI in breast cancer (BC) patients in chemotherapy treatment (CT+) or not (CT−) and to analyze their relationship with detectable objective changes in cerebral activity during the execution of a phonological and semantic verbal fluency task (PVF and SVF). Methods: An observational, cross-sectional study was carried out at Badajoz University Hospital (Spain). A total of 180 women with BC were included. We used Cognitive Scale (FACT-Cog) for neuropsychological subjective assessment, obtaining scores of perceived cognitive impairment (PCI), and near-infrared spectroscopy system (NIRS) for neuropsychological objective assessment during a verbal fluency task (PVF and SVF), determining alterations in the prefrontal cortex (PFC) assessed as changes in regional saturation index (rSO2). Results: A total of 41.7% percent of the patients in the sample had PCI. CT+ was significantly associated with a worse impact in PCI ( = 50.60 ± 15.64 vs. = 55.01 ± 12.10; p = 0.005). Average rSO2 decreased significantly in CT+ ( = 63.30 ± 8.02 vs. = 67.98 ± 7.80; p < 0.001), and BC patients showed a significant decrease in PVF and SVF on average ( = 41.99 ± 9.52 vs. = 47.03 ± 9.31, = 33.43 ± 11.0 vs. = 36.14 ± 10.68, respectively; p < 0.001). Conclusions: Our findings suggest that cognitive impairments in the domain of executive functioning exist among patients with BC who received CT. The results corroborate the hypothesis that CT is an important factor in cognitive impairment in patients with BC, which has been demonstrated by both subjective (PCI) and objective (PVF, SVF, and rSO2) neuropsychological measures. The combination of doxorubicin, cyclophosphamide, and docetaxel induce cognitive impairment.
Background: Shift working is associated with a profound desynchronization of circadian rhythm and in particular, night-shift work disrupts normal circadian physiology. Sleep deprivation affects the functioning of certain brain areas and thus impairs cognitive performance. The purpose of this study was to investigate the effects of the night shift on cognitive performance and cerebral oxygenation/haemodynamics. Methods: A prospective, observational, comparative, randomized and cross-over study was carried out. A total of 74 intensive care unit nurses in Spain were included in the study. The following variables were measured: sociodemographic, burnout, anxiety, baseline cerebral oxygenation levels on night and day shift using a near-infrared spectroscopy system and cognitive task performance during a verbal fluency task to evaluate the alterations in the prefrontal cortex, assessed as changes in regional saturation index. Results: The average regional saturation index decreased significantly in the night shift (r = 0.560, p < 0.001). The ICU nurses showed a significant decrease in the verbal fluency test on average (8.53 ± 8.49, p < 0.001) and, in general, there was also a significant increase in anxiety score (3.17 ± 7.56, p = 0.001). Conclusions: Sleep deprivation during the night shift was considered to be related to decreased dorsolateral PFC reactivity. After the night shift, the nurses showed a decrease in prefrontal cortex activity and in cognitive performance.
Breast cancer is the most common neoplasm among women, and sleep disturbances are prevalent symptoms that affect their quality of life. Despite evidence suggesting that sleep problems are common in this population, there is a lack of research that comprehensively analyses these aspects. This study focuses on assessing sleep quality, insomnia severity and its impact on several variables, including health-related quality of life, in women diagnosed with breast cancer. To assess sleep quality, insomnia severity and its impact on several variables, including health-related quality of life, in women diagnosed with breast cancer. An observational study was conducted with 245 women diagnosed with breast cancer. Participants with conditions that could interfere with sleep were excluded. Standardised questionnaires, such as the Pittsburgh Sleep Quality Index and the Insomnia Severity Index, were used. In addition, the European Organization for the Research and Treatment of Cancer Quality of Life and Breast Cancer Questionnaires were administered and sociodemographic, clinical and treatment-related variables were recorded. Almost 66% of the participants reported poor sleep quality. Sleep disturbances were associated with a significant deterioration in participants’ quality of life, affecting both their daily functioning and intensity of the symptoms experienced. Women in chemotherapy treatment showed greater severity of insomnia (8.30 ± 6.36; p < 0.001) and significantly worse sleep quality (8.80 ± 4.91; p < 0.001). A greater number of chemotherapy cycles was also associated with an increase in insomnia symptoms (p = 0.015). Women with breast cancer experience a high prevalence of sleep disturbances, which negatively impacts their quality of life. The need to systematically identify and address sleep problems throughout treatment and recovery is emphasised, as these disturbances can affect patients’ overall well-being and functional ability.
18 October 2025 in International Journal of Mental Health Nursing
Burnout affects a significant proportion of nursing students and is characterised by emotional exhaustion, depersonalisation, and a diminished sense of accomplishment. Previous studies have reported that the overall prevalence of academic burnout among nursing students is approximately 46%. Given the demanding nature of nursing education, identifying effective strategies to mitigate burnout is essential for fostering competent and resilient healthcare professionals. To assess the emotional intelligence levels of nursing students and evaluate the effectiveness of Simulation‐Based Learning Experiences (SBLE) in reducing burnout. An experimental study was conducted according to the TREND checklist with nursing students assigned to either an intervention group, which participated in SBLE, or a control group, which received traditional classroom instruction. Emotional intelligence was measured using the Trait Meta‐Mood Scale, while burnout levels were assessed using the Maslach Burnout Inventory‐Student Survey at baseline and post‐intervention. A total of 240 nursing students participated (intervention group: n = 133; control group: n = 107). Pre‐intervention analysis revealed no significant differences in emotional intelligence between the groups. Following the intervention, the intervention group exhibited significant reductions in emotional exhaustion (mean change = −0.87, p < 0.001) and cynicism (mean change = −0.54, p < 0.001), alongside a significant increase in perceived efficacy (mean change = +0.78, p < 0.001). The control group demonstrated no significant changes. A repeated‐measures ANOVA confirmed the significant impact of the intervention on burnout dimensions ( p < 0.001). The findings suggest that SBLE is an effective approach for reducing burnout among nursing students. The intervention group demonstrated substantial improvements in exhaustion, cynicism, and perceived efficacy, while no meaningful changes were observed in the control group.
Background: A considerable proportion of breast cancer (BC) patients experience chemotherapy-related cognitive impairment (CRCI) and other symptoms even after the completion of treatment. The persistence of CRCI throughout the oncological process highlights the need for routine assessment of its severity, impact on quality of life, and the effectiveness of interventions aimed at addressing it. Objectives: To analyse the effectiveness of cognitive stimulation interventions on CRCI in BC patients and to identify the characteristics of such interventions, including the most appropriate timing for their implementation, the most suitable techniques, and their duration. Methodology: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. Randomized controlled trials published between 1 January 2020 and 31 December 2024 were searched across three electronic databases. Studies involving cognitive stimulation interventions for the management of CRCI in BC patients were included. Results: A total of 12 eligible studies were identified for the systematic review and 10 for the meta-analysis. The review revealed a wide range of cognitive stimulation interventions, differing in techniques, duration, format, and timing of implementation. Group-based therapies lasting between 6 and 12 weeks predominated, with cognitive outcomes primarily assessed using the FACT-Cog scale. The meta-analysis demonstrated a moderate positive effect of cognitive stimulation interventions on cognitive functioning in BC patients (d = 0.59), although not statistically significant (p = 0.07), and showed high heterogeneity across studies (I2 = 93%). Conclusions: Cognitive stimulation interventions show potential benefits in improving cognitive functioning in BC patients following chemotherapy. However, the high methodological heterogeneity limits the strength of the evidence. Further research is needed to develop standardized and personalized early intervention protocols.
About Me
Professor at the University of Extremadura since 2015
Professor at the University of Extremadura since 2015